Please assess the completion status of the following clinical trial:

Trial Title: A Study on the Angioarchitecture of Hepatocellular Carcinoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Age above 18 years~2. HCC suitable for partial hepatectomy~3. Child-Pugh A or B cirrhosis~4. Eastern Cooperative Oncology Group performance score 0 or 1~5. Barcelona clinic liver cancer (BCLC) staging A or B~6. HCC diagnosed by typical enhancement patterns on cross sectional imaging or histology~7. Massive expansive tumor morphology with measurable lesion on CT (characterized by well-defined spherical or globular configuration, with or without tumor capsule or satellite lesions)~Exclusion Criteria:~1. Previous treatment with liver resection, ablation, chemotherapy, radiotherapy or transarterial embolization (with or without chemotherapy),~2. Evidence of tumor invasion of portal vein or hepatic vein~3. History of acute tumor rupture presenting with hemo-peritoneum~4. Infiltrative tumor morphology (characterized by ill- defined tumor margin and amorphous configuration) or diffuse tumor morphology (characterized by large number of small nodules)~5. Serum creatinine level \> 150umol/L

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tumor <=3cm (Type: OTHER): Embolization with particulate or liquid embolic agent
- Tumor >3cm to 7cm (Type: OTHER): Embolization with particulate or liquid embolic agent
- Tumor > 7cm (Type: OTHER): Embolization with particulate or liquid embolic agent

Based on this trial design, predict the completion outcome and termination type (if applicable).